KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to 0.03%.

  • Biogen's Return on Capital Employed fell 100.0% to 0.03% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.03%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.03% for FY2025, which is 100.0% down from last year.
  • Latest data reveals that Biogen reported Return on Capital Employed of 0.03% as of Q4 2025, which was down 100.0% from 0.02% recorded in Q3 2025.
  • Biogen's Return on Capital Employed's 5-year high stood at 0.18% during Q1 2021, with a 5-year trough of 0.05% in Q4 2023.
  • Over the past 5 years, Biogen's median Return on Capital Employed value was 0.01% (recorded in 2023), while the average stood at 0.04%.
  • Per our database at Business Quant, Biogen's Return on Capital Employed plummeted by -2200bps in 2021 and then surged by 400bps in 2022.
  • Quarter analysis of 5 years shows Biogen's Return on Capital Employed stood at 0.15% in 2021, then decreased by -25bps to 0.11% in 2022, then plummeted by -147bps to 0.05% in 2023, then surged by 65bps to 0.02% in 2024, then tumbled by -83bps to 0.03% in 2025.
  • Its Return on Capital Employed stands at 0.03% for Q4 2025, versus 0.02% for Q3 2025 and 0.03% for Q2 2025.